Nurs 5336 Module 2 Quiz - Part 3 exam
questions with correct answers
The |2017 |ACC/AHA |hypertension |guidelines |call |for |HBP |(high |blood |pressure) |to |be |treated |with |
lifestyle |changes |and/or |medication |as |indicated |beginning |at |___ |- |VERIFIED |ANSWER✔✔-130/80 |
mmHg
The |JNC |8 |hypertension |guidelines |call |for |HBP |(high |blood |pressure) |to |be |treated |at |the |accepted |
threshold |of |___ |- |VERIFIED |ANSWER✔✔-140/90 |mmHg
Approximately |50% |of |CVD |(cardiovascular |disease) |events |occur |at |BPs |(blood |pressures) |of |___ |- |
VERIFIED |ANSWER✔✔-120-140
One |study/trial |that |showed |positive |results |when |patients |were |treated |with |BP |of |less |than |120/80 |
was |___ |- |VERIFIED |ANSWER✔✔-SPRINT
Why |do |not |all |agree |with |the |SPRINT |findings? |- |VERIFIED |ANSWER✔✔-New |guidelines |ignore |the |
risks |of |treatment |goals |like |hypotension, |falls, |and |renal |failure
Using |the |DASH |diet |approximately |reduces |SBP |(systolic |blood |pressure) |by |how |much |in |a |patient |
with |hypetension? |- |VERIFIED |ANSWER✔✔-11 |mmHg
Adults |with |an |elevated |blood |pressure |or |stage |1 |hypertension |who |have |an |estimated |10-year |
ASCVD |risk |less |than |10% |should |be |managed |with |___ |and |have |a |repeat |blood |pressure |evaluation |
within |___ |- |VERIFIED |ANSWER✔✔-- |non-pharmacological |therapy
- |3 |to |6 |months
Adults |with |stage |1 |hypertension |who |have |an |estimated |10-year |ASCVD |risk |of |10% |or |higher |should
|be |managed |initially |with |a |combination |of |___ |and |___ |and |have |a |repeat |blood |pressure |evaluation
|within |___ |- |VERIFIED |ANSWER✔✔-- |non-pharmacological |
- |anti-hypertensive |drug |therapy
- |1 |month
questions with correct answers
The |2017 |ACC/AHA |hypertension |guidelines |call |for |HBP |(high |blood |pressure) |to |be |treated |with |
lifestyle |changes |and/or |medication |as |indicated |beginning |at |___ |- |VERIFIED |ANSWER✔✔-130/80 |
mmHg
The |JNC |8 |hypertension |guidelines |call |for |HBP |(high |blood |pressure) |to |be |treated |at |the |accepted |
threshold |of |___ |- |VERIFIED |ANSWER✔✔-140/90 |mmHg
Approximately |50% |of |CVD |(cardiovascular |disease) |events |occur |at |BPs |(blood |pressures) |of |___ |- |
VERIFIED |ANSWER✔✔-120-140
One |study/trial |that |showed |positive |results |when |patients |were |treated |with |BP |of |less |than |120/80 |
was |___ |- |VERIFIED |ANSWER✔✔-SPRINT
Why |do |not |all |agree |with |the |SPRINT |findings? |- |VERIFIED |ANSWER✔✔-New |guidelines |ignore |the |
risks |of |treatment |goals |like |hypotension, |falls, |and |renal |failure
Using |the |DASH |diet |approximately |reduces |SBP |(systolic |blood |pressure) |by |how |much |in |a |patient |
with |hypetension? |- |VERIFIED |ANSWER✔✔-11 |mmHg
Adults |with |an |elevated |blood |pressure |or |stage |1 |hypertension |who |have |an |estimated |10-year |
ASCVD |risk |less |than |10% |should |be |managed |with |___ |and |have |a |repeat |blood |pressure |evaluation |
within |___ |- |VERIFIED |ANSWER✔✔-- |non-pharmacological |therapy
- |3 |to |6 |months
Adults |with |stage |1 |hypertension |who |have |an |estimated |10-year |ASCVD |risk |of |10% |or |higher |should
|be |managed |initially |with |a |combination |of |___ |and |___ |and |have |a |repeat |blood |pressure |evaluation
|within |___ |- |VERIFIED |ANSWER✔✔-- |non-pharmacological |
- |anti-hypertensive |drug |therapy
- |1 |month
